|Last Price||Today's Change||52-Week Range||Trading Volume|
|0.44 CAD||0.00 (0.00%)||0.39 - 0.88||0.0|
Market data as of 12:00AM 12/18/14. Quotes are delayed by at least 15 min.
Antibe Therapeutics Announces Appointment of Canadian Rheumatologist J. Carter Thorne to Its Clinical Advisory Board
Business Wire - Thursday 12/18/2014 7:45 AM ET
Antibe Therapeutics Announces Appointment of US-Based Investor Relations Consultant
Business Wire - Tuesday 12/16/2014 7:45 AM ET
Antibe Therapeutics Reports Q2 2015 Interim Financial and Operating Results
Business Wire - Friday 11/28/2014 7:45 AM ET
Antibe Therapeutics Provides Update on Its Acute Pain Drug ATB-352
Business Wire - Tuesday 11/25/2014 7:30 AM ET
|Revenue Growth (1yr)||--|
|Net Income Growth (1yr)||--|
Data is delayed by at least 15 min.